Keeping clinical development strategy on track: early decisions that reduce risk and delays

Clinical development strategy is often shaped long before a study begins

Early decisions around trial design, endpoint selection, data strategy and regulatory planning can have a lasting impact on development success. For small and mid-sized biotechs, aligning clinical, data and regulatory teams early is critical to navigating complexity, meeting key milestones and avoiding costly delays.

Watch this on-demand webinar to learn how a more integrated approach to clinical development can reduce risk, improve cross-functional collaboration and support a stronger path to first patient in (FPI). You’ll gain practical strategies to strengthen your development plan from the start.

You will learn how to:

Identify early sources of strategic and operational misalignment

Evaluate how clinical, data, and regulatory decisions impact execution later in development

Strengthen development planning to better support key milestones, including FPI

Assess how integrated operating models can help reduce downstream risk

Meet our experts:

Gerri Baer, MD, FAAP
Vice President, Strategic Scientific Solutions, PPD clinical research business of Thermo Fisher Scientific

TJ Stalvey
Vice President, Neurosciences, PPD clinical research business of Thermo Fisher Scientific

Ariel Berger, MPH
Executive Director, Integrated Solutions, Real-World Data & Scientific Solutions, PPD clinical research business of Thermo Fisher Scientific

Shyam Banuprakash
Vice President, Data Science & Data Delivery for Medical Imaging, Clario digital endpoint solutions for Thermo Fisher Scientific

Vanessa Elharrar, MD, MPH (Moderator)
Vice President and Global Medical Officer, PPD clinical research business of Thermo Fisher Scientific

Get the webinar recording

Access the webinar to gain practical insights